NRAS and RASopathy: Interestingly, in addition to patients with KRAS, NRAS, and BRAF mutations, we found that MM exhibited a long tail of alterations in rare, congenital RAS-pathway-related diseases, known as the “Rasopathies” (Fig. 3a, bottom right panel, Fig. 3b).